drugset / Trial / NCT02999191

Relative Bioavailability of BI 1467335 Tablet and Oral Solution, and Food Effect on Tablet in Healthy Male Subjects

NCT02999191

Phase 1 Completed 18 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

The primary objective of this trial is to investigate the relative bioavailability of BI 1467335, given as film-coated tablet compared to BI 1467335, given as oral solution. This assessment will be performed under fasted conditions. Furthermore, the effect of food on relative bioavailability of the tablet formulation of BI 1467335 will be investigated.

Timeline

Start
2017-01-10
Primary completion
2017-03-15
Completion
2017-04-10

Drugs

EvaluationDrugModalityDoseRoute
Subject BI 1467335 Unknown Oral

Indications

No indication recorded.